日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Breaking the barrier: disruption of bacterial biofilms using microwave radiation

突破屏障:利用微波辐射破坏细菌生物膜

Ben, Harita; Agarwal, Harshita; Gurnani, Bharat; Pradhan, Aman A; Khan, Arani Ali; Jain, Neha

Optimization of lentiviral delivery of barcoded anti-CD20 chimeric antigen receptors into rhesus macaque and human natural killer cells

优化利用慢病毒载体将带有条形码的抗CD20嵌合抗原受体递送至恒河猴和人类自然杀伤细胞

Hayal, Taha B; Mulla, Aman A; Allan, David S J; Duncan, Brynn B; Joshi, Saanika; Hong, So Gun; Basar, Rafet; Rezvani, Katayoun; Childs, Richard W; Wu, Chuanfeng; Dunbar, Cynthia E

Asymptomatic Carotid Stenosis is Associated With Mobility Dysfunction: Results From the InChianti Study

无症状颈动脉狭窄与行动功能障碍相关:来自 InChianti 研究的结果

Desikan, Sarasijhaa K; Borrelli, James; Gray, Vicki L; Kankaria, Aman A; Terrin, Michael; Lal, Brajesh K

Cognitive impairment in asymptomatic carotid artery stenosis is associated with abnormal segments in the Circle of Willis

无症状颈动脉狭窄患者的认知障碍与威利斯环的异常节段有关。

Desikan, Sarasijhaa K; Brahmbhatt, Binal; Patel, Jigar; Kankaria, Aman A; Anagnostakos, John; Dux, Moira; Beach, Kirk; Gray, Vicki L; McDonald, Tara; Crone, Caroline; Sikdar, Siddhartha; Sorkin, John D; Lal, Brajesh K

Accessing Grignard Reluctant Aldehyde in 2-Oxoaldehyde by Organocuprates to Give [1,2] Addition and Oxidative Coupling Reactions

利用有机铜试剂在2-氧代醛中合成格氏试剂难反应醛,实现[1,2]加成和氧化偶联反应

Battula, Satyanarayana; Desai, Aman A; Soni, Jigar Y; Mehta, Dhruv P

Developing fMRI protocol for clinical use Comparison of 6 Arabic paradigms for brain language mapping in native Arabic speakers

开发用于临床的fMRI方案;比较6种阿拉伯语范式在母语为阿拉伯语者大脑语言映射中的应用

Mohtasib, Rafat S; Alghamdi, Jamaan S; Baz, Salah M; Aljoudi, Haya F; Masawi, Ahmed M; Jobeir, Aman A

Association of VDR Gene Variant (rs1544410) with Type 2 Diabetes in a Pakistani Cohort

维生素D受体基因变异(rs1544410)与巴基斯坦人群中2型糖尿病的关联性研究

Khan, A; Khan, S; Aman, A; Ali, Y; Jamal, M; Rahman, B; Ahmad, M; Aasim, M; Jalil, F; Shah, A A

FV-162 is a novel, orally bioavailable, irreversible proteasome inhibitor with improved pharmacokinetics displaying preclinical efficacy with continuous daily dosing

FV-162 是一种新型的、口服生物利用度高的、不可逆的蛋白酶体抑制剂,具有改进的药代动力学,在临床前研究中显示出每日持续给药的疗效。

Wang, Z; Dove, P; Wang, X; Shamas-Din, A; Li, Z; Nachman, A; Oh, Y J; Hurren, R; Ruschak, A; Climie, S; Press, B; Griffin, C; Undzys, E; Aman, A; Al-awar, R; Kay, L E; O'Neill, D; Trudel, S; Slassi, M; Schimmer, A D

Self-Assembly of a Library of Polyborate Chiral Anions for Asymmetric Catalytic Quinoline Reduction

利用自组装构建聚硼酸手性阴离子库用于不对称催化喹啉还原

Desai, Aman A; Guan, Yong; Odom, Aaron L; Majumder, Supriyo; Wulff, William D